Sermorelin and Tesamorelin are both growth hormone-releasing hormone (GHRH) analogues that stimulate the pituitary gland to produce and secrete growth hormone naturally. Despite their shared mechanism, they differ meaningfully in potency, clinical indication, and cost.
How They Work
Sermorelin is a truncated form of natural GHRH, containing the first 29 amino acids of the 44-amino-acid GHRH molecule (GHRH(1-29)). These 29 amino acids contain the full biologically active sequence needed to bind and activate the GHRH receptor on pituitary somatotrophs, triggering growth hormone release.
Tesamorelin is a modified form of the full-length GHRH(1-44) molecule with a trans-3-hexenoic acid group attached to the tyrosine at position 1. This modification increases resistance to enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV), resulting in a longer half-life and more potent GH stimulation per dose.
Both work with the body's natural feedback mechanisms — they stimulate GH release but do not override the somatostatin negative feedback loop, making them safer than exogenous HGH.
What the Research Shows
Sermorelin has decades of clinical use data. It was originally FDA-approved for pediatric growth hormone deficiency and has been widely used off-label in anti-aging medicine. Studies show it effectively raises IGF-1 levels, improves body composition, enhances sleep quality, and supports tissue repair.
Tesamorelin has more recent but highly specific clinical data. The FDA approved it in 2010 for HIV-associated lipodystrophy based on trials showing a 15-18% reduction in visceral adipose tissue (VAT). Additional research has demonstrated improvements in hepatic fat, cognitive function (particularly in mild cognitive impairment), and cardiometabolic markers.
Side Effects and Tolerability
Both peptides are well tolerated. Common side effects for both include injection site reactions (redness, swelling), headache, and flushing.
Sermorelin may cause brief facial flushing immediately after injection due to the GH pulse. Tesamorelin carries a slightly higher rate of peripheral edema and arthralgia, consistent with its stronger GH-elevating effect.
Both are contraindicated in active malignancy due to the theoretical risk of GH-mediated tumor growth.
How to Choose
Choose Sermorelin if: your goals are general anti-aging, improved sleep, better skin and hair quality, and moderate body composition improvement. It is also the better choice if cost is a primary consideration, as it is significantly less expensive.
Choose Tesamorelin if: visceral fat reduction is your primary objective, you have metabolic syndrome or elevated liver fat, or you want the most potent GHRH stimulation available. Its FDA-approved status for lipodystrophy provides additional clinical confidence.